Equol

Last updated
Equol
Equol structure.png
Names
IUPAC name
(3S)-Isoflavan-4,7′-diol
Systematic IUPAC name
(3S)-3-(4-Hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-7-ol
Other names
4',7-Isoflavandiol
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
ECHA InfoCard 100.007.749 OOjs UI icon edit-ltr-progressive.svg
KEGG
PubChem CID
UNII
  • InChI=1S/C15H14O3/c16-13-4-1-10(2-5-13)12-7-11-3-6-14(17)8-15(11)18-9-12/h1-6,8,12,16-17H,7,9H2/t12-/m1/s1 Yes check.svgY
    Key: ADFCQWZHKCXPAJ-GFCCVEGCSA-N Yes check.svgY
  • InChI=1/C15H14O3/c16-13-4-1-10(2-5-13)12-7-11-3-6-14(17)8-15(11)18-9-12/h1-6,8,12,16-17H,7,9H2/t12-/m1/s1
    Key: ADFCQWZHKCXPAJ-GFCCVEGCBP
  • C1C(COC2=C1C=CC(=C2)O)C3=CC=C(C=C3)O
  • Oc1ccc(cc1)[C@@H]2Cc3c(OC2)cc(O)cc3
Properties
C15H14O3
Molar mass 242.274 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Yes check.svgY  verify  (what is  Yes check.svgYX mark.svgN ?)

Equol (4',7-isoflavandiol) is an isoflavandiol [1] estrogen metabolized from daidzein, a type of isoflavone found in soybeans and other plant sources, by bacterial flora in the intestines. [2] [3] While endogenous estrogenic hormones such as estradiol are steroids, equol is a nonsteroidal estrogen. Only about 30–50% of people have intestinal bacteria that make equol. [4]

Contents

History

(S)-Equol was first isolated from horse urine in 1932, [5] and the name was suggested by this equine connection. [6] Since then, equol has been found in the urine or plasma of many other animal species, although these animals have significant differences in their ability to metabolize daidzein into equol. [6] In 1980, scientists reported the discovery of equol in humans. [7] The ability of (S)-equol to play a role in the treatment of estrogen- or androgen-mediated diseases or disorders was first proposed in 1984. [8]

Chemical structure

Equol is a compound that can exist in two mirror-image forms known as enantiomers: (S)-equol and (R)-equol. (S)-equol is produced in humans and animals with the ability to metabolize the soy isoflavone daidzein, while (R)-equol can be chemically synthesized. [9] The molecular and physical structure of (S)-equol is similar to that of the hormone estradiol. [10] (S)-Equol preferentially binds estrogen receptor beta. [2] [11]

Pharmacology

Estrogen receptor binding

(S)-equol is a nonsteroidal, selective agonist of ERβ (Ki = 16 nM) with 13-fold selectivity for ERβ over ERα. [3] Relative to (S)-equol, (R)-equol is less potent and binds to ERα (Ki = 50 nM) with 3.5-fold selectivity over ERβ. [3] (S)-Equol has about 2% of estradiol's binding affinity for human estrogen receptor alpha (ERα) and 20% of estradiol's binding affinity for human estrogen receptor beta (ERβ). The preferential binding of (S)-equol to ERβ vs. ERα and in comparison to that of estradiol suggests the molecule may share some of the characteristics of a selective estrogen receptor modulator (SERM). [12] Equol has been found to act as an agonist of the GPER (GPR30). [13]

Pharmacokinetics

(S)-Equol is a very stable molecule that essentially remains unchanged when digested, and this lack of further metabolism explains its very quick absorption and high bioavailability. [14] When (S)-equol is consumed, it is rapidly absorbed and achieves a Tmax (rate of peak plasma concentration) in two to three hours. In comparison, the Tmax of daidzein is 4 to 10 hours because daidzein exists in glycoside (with a glucose side chain) form. The body must convert daidzein to its aglycone form (without the glucose side chain) via removal of the sugar side chain during digestion before it can use daidzein. If consumed directly in aglycone form, daidzein has a Tmax of one to three hours. [15] The percent fractional elimination of (S)-equol in urine after oral administration is high and in some adults can reach close to 100 percent. The percent fractional elimination of daidzein is much lower at 30 to 40 percent. [16]

Production in humans

To produce (S)-equol after soy consumption, humans must have certain strains of bacteria living within their intestines. [8] Twenty-one different strains of intestinal bacteria cultured from humans have been shown to have the ability to transform daidzein into (S)-equol or a related intermediate compound. [6] Several studies indicate that only 25 to 30 percent of the adult populations of Western countries produce (S)-equol after eating soy foods containing isoflavones, [10] [17] [18] [19] while 50 to 60 percent of adults from Japan, Korea, and China are equol-producers. [20] [21] [22] [23] Vegetarians have also been reported to be more capable of transforming daidzein into (S)-equol. [24] Seaweed and dairy consumption can enhance the production of equol. [10] [25] The ability of a person to produce (S)-equol is determined by testing people who have not taken any antibiotics for at least a month. For this standardized test, the individual drinks two 240 milliliter glasses of soy milk or eats a soy food equivalent for three days. The (S)-equol concentration in each test subject's urine is determined on day four. [26]

Equol producing bacteria

While many more bacteria are involved in the related intermediate process of equol production, such as conversion of daidzin to daidzein, or genistein to 5-Hydroxy-equol, the bacteria that achieve the complete conversion of daidzein to (S)-equol, [27] include: [28]

Conversion by Bifidobacterium has only been reported once by Tsangalis et al. in 2002 [29] and not reproduced since.Bifidobacteria: Genomics and Molecular Aspects Mixed cultures such as Lactobacillus sp. Niu-O16 and Eggerthella sp. Julong 732 can also produce (S)-equol.Bifidobacteria: Genomics and Molecular Aspects Some equol producing bacteria, as implied by their nomenclature, are Adlercreutzia equolifaciens, Slackia equolifaciens and Slackia isoflavoniconvertens.

Health effects

Skin health

The topical effects of equol as an anti-aging substance have been shown in different studies. The effects result from both molecular and structural changes to the skin. Equol can, for instance, lead to an increase in telomere length. As an antioxidant, equol can decrease the aging process by reducing damage caused by reactive oxygen species (ROS). It may also act as a protective anti-photoaging substance by inhibiting acute UVA- induced lipid peroxidation. [30] In addition, equol may have a positive impact on epigenetic regulation. [31] Equol's phytoestrogenic properties may also affect skin health. [32] Reduction of dark circles and eye wrinkles after treatment with equol has been reported. [33] Equol may also protect skin from damage by pollution due to its anti-oxidative and anti-inflammatory properties. [34]

Each of the enantiomers and the racemic mixture of both enantiomers have different characteristics, bioavailabilities and molecular effects. [35] According to one study, (RS)-equol provided the greatest overall improvement in skin health, especially when applied topically. [35]

Beyond topical effects, medicinal equol has been shown to relieve menopausal symptoms such as hot flashes and muscle and joint pain. [36] [37] (RS)-equol was also reported to reduce symptoms associated with menopausal vaginal atrophy, such as vaginal itching, vaginal dryness and pain with intercourse and cause positive shifts in the vaginal bacterial population, cell composition, and pH. [38]

According to animal studies, [39] it has anti-androgenic effects and may lead to inhibited 5-alpha reductase as well as lowered dihydrotestosterone (DHT) levels.

See also

Related Research Articles

<span class="mw-page-title-main">Estriol</span> Chemical compound

Estriol (E3), also spelled oestriol, is a steroid, a weak estrogen, and a minor female sex hormone. It is one of three major endogenous estrogens, the others being estradiol and estrone. Levels of estriol in women who are not pregnant are almost undetectable. However, during pregnancy, estriol is synthesized in very high quantities by the placenta and is the most produced estrogen in the body by far, although circulating levels of estriol are similar to those of other estrogens due to a relatively high rate of metabolism and excretion. Relative to estradiol, both estriol and estrone have far weaker activity as estrogens.

<span class="mw-page-title-main">Phytoestrogen</span> Plant-derived xenoestrogen

A phytoestrogen is a plant-derived xenoestrogen not generated within the endocrine system, but consumed by eating plants or manufactured foods. Also called a "dietary estrogen", it is a diverse group of naturally occurring nonsteroidal plant compounds that, because of its structural similarity to estradiol (17-β-estradiol), have the ability to cause estrogenic or antiestrogenic effects. Phytoestrogens are not essential nutrients because their absence from the diet does not cause a disease, nor are they known to participate in any normal biological function. Common foods containing phytoestrogens are soy protein, beans, oats, barley, rice, coffee, apples, carrots.

Isoflavones are substituted derivatives of isoflavone, a type of naturally occurring isoflavonoids, many of which act as phytoestrogens in mammals. Isoflavones are produced almost exclusively by the members of the bean family, Fabaceae (Leguminosae).

<span class="mw-page-title-main">Genistein</span> Chemical compound

Genistein (C15H10O5) is a naturally occurring compound that structurally belongs to a class of compounds known as isoflavones. It is described as an angiogenesis inhibitor and a phytoestrogen.

<span class="mw-page-title-main">Daidzein</span> Chemical compound

Daidzein is a naturally occurring compound found exclusively in soybeans and other legumes and structurally belongs to a class of compounds known as isoflavones. Daidzein and other isoflavones are produced in plants through the phenylpropanoid pathway of secondary metabolism and are used as signal carriers, and defense responses to pathogenic attacks. In humans, recent research has shown the viability of using daidzein in medicine for menopausal relief, osteoporosis, blood cholesterol, and lowering the risk of some hormone-related cancers, and heart disease. Despite the known health benefits, the use of both puerarin and daidzein is limited by their poor bioavailability and low water solubility.

<span class="mw-page-title-main">Isoflavonoid</span> Class of chemical compound

Isoflavonoids are a class of flavonoid phenolic compounds, many of which are biologically active. Isoflavonoids and their derivatives are sometimes referred to as phytoestrogens, as many isoflavonoid compounds have biological effects via the estrogen receptor.

<span class="mw-page-title-main">Estrogen receptor beta</span> Protein-coding gene in the species Homo sapiens

Estrogen receptor beta (ERβ) also known as NR3A2 is one of two main types of estrogen receptor—a nuclear receptor which is activated by the sex hormone estrogen. In humans ERβ is encoded by the ESR2 gene.

<span class="mw-page-title-main">Estetrol</span> Chemical compound

Estetrol (E4), or oestetrol, is one of the four natural estrogenic steroid hormones found in humans, along with estrone (E1), estradiol (E2), and estriol (E3). Estetrol is a major estrogen in the body. In contrast to estrone and estradiol, estetrol is a native estrogen of fetal life. Estetrol is produced exclusively by the fetal liver and is found in detectable levels only during pregnancy, with relatively high levels in the fetus and lower levels in the maternal circulation.

<span class="mw-page-title-main">Formononetin</span> Chemical compound

Formononetin is an O-methylated isoflavone.

Menerba, also known as Menopause Formula 101 (MF-101), is a botanical drug candidate that acts as a selective estrogen receptor modulator (SERM) which is being studied for its potential to relieve hot flashes associated with menopause. Menerba, an estrogen receptor beta (ERβ) agonist (ERBA), is part of a new class of receptor subtype-selective estrogens, which is selective in transcriptional regulation to one of the two known estrogen receptor (ER) subtypes. Menerba consists of 22 herbs that have been used historically in traditional Chinese medicine.

<span class="mw-page-title-main">3β-Androstanediol</span> Chemical compound

3β-Androstanediol, also known as 5α-androstane-3β,17β-diol, and sometimes shortened in the literature to 3β-diol, is an endogenous steroid hormone and a metabolite of androgens like dehydroepiandrosterone (DHEA) and dihydrotestosterone (DHT).

<span class="mw-page-title-main">8-Prenylnaringenin</span> Chemical compound

8-Prenylnaringenin (8-PN; also known as flavaprenin, (S)-8-dimethylallylnaringenin, hopein, or sophoraflavanone B) is a prenylflavonoid phytoestrogen. It is reported to be the most estrogenic phytoestrogen known. The compound is equipotent at the two forms of estrogen receptors, ERα and ERβ, and it acts as a full agonist of ERα. Its effects are similar to those of estradiol, but it is considerably less potent in comparison.

<span class="mw-page-title-main">Estrogen and neurodegenerative diseases</span>

Neurodegenerative diseases can disrupt the normal human homeostasis and result in abnormal estrogen levels. For example, neurodegenerative diseases can cause different physiological effects in males and females. In particular, estrogen studies have revealed complex interactions with neurodegenerative diseases. Estrogen was initially proposed to be a possible treatment for certain types of neurodegenerative diseases but a plethora of harmful side effects such as increased susceptibility to breast cancer and coronary heart disease overshadowed any beneficial outcomes. On the other hand, Estrogen Replacement Therapy has shown some positive effects with postmenopausal women. Estrogen and estrogen-like molecules form a large family of potentially beneficial alternatives that can have dramatic effects on human homeostasis and disease. Subsequently, large-scale efforts were initiated to screen for useful estrogen family molecules. Furthermore, scientists discovered new ways to synthesize estrogen-like compounds that can avoid many side effects.

<span class="mw-page-title-main">17α-Estradiol</span> Chemical compound

17α-Estradiol is a minor and weak endogenous steroidal estrogen that is related to 17β-estradiol. It is the C17 epimer of estradiol. It has approximately 100-fold lower estrogenic potency than 17β-estradiol. The compound shows preferential affinity for the ERα over the ERβ. Although 17α-estradiol is far weaker than 17β-estradiol as an agonist of the nuclear estrogen receptors, it has been found to bind to and activate the brain-expressed ER-X with a greater potency than that of 17β-estradiol, suggesting that it may be the predominant endogenous ligand for the receptor.

<i>O</i>-Desmethylangolensin Chemical compound

O-Desmethylangolensin (O-DMA) is a phytoestrogen. It is an intestinal bacterial metabolite of the soy phytoestrogen daidzein. It produced in some people, deemed O-DMA producers, but not others. O-DMA producers were associated with 69% greater mammographic density and 6% bone density.

<span class="mw-page-title-main">Estradiol glucuronide</span> Chemical compound

Estradiol glucuronide, or estradiol 17β-D-glucuronide, is a conjugated metabolite of estradiol. It is formed from estradiol in the liver by UDP-glucuronyltransferase via attachment of glucuronic acid and is eventually excreted in the urine by the kidneys. It has much higher water solubility than does estradiol. Glucuronides are the most abundant estrogen conjugates.

<span class="mw-page-title-main">ERB-196</span> Chemical compound

ERB-196, also known as WAY-202196, is a synthetic nonsteroidal estrogen that acts as a highly selective agonist of the ERβ. It possesses 78-fold selectivity for the ERβ over the ERα. The drug was under development by Wyeth for the treatment of inflammation and sepsis starting in 2004 but development was discontinued by 2011.

Slackia isoflavoniconvertens is a bacterium from the genus of Slackia which has been isolated from faeces of a human from Nuthetal in Germany. Slackia isoflavoniconvertens can metabolize daidzein and genistein, two compounds in the class of isoflavones.

<i>Soy boy</i> Pejorative term for men perceived as non-masculine

Soy boy is a pejorative term sometimes used in online communities to describe men perceived to be lacking masculine characteristics. The term bears many similarities and has been compared to the slang terms cuck, nu-male and low-T – terms sometimes used as an insult for male femininity by online communities.

<span class="mw-page-title-main">4-Methoxyestriol</span> Chemical compound

4-Methoxyestriol (4-MeO-E3) is an endogenous estrogen metabolite. It is the 4-methyl ether of 4-hydroxyestriol and a metabolite of estriol and 4-hydroxyestriol. 4-Methoxyestriol has very low affinities for the estrogen receptors. Its relative binding affinities (RBAs) for estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ) are both about 1% of those of estradiol. For comparison, estriol had RBAs of 11% and 35%, respectively.

References

  1. ↑ The structures of 7,4’-dihydroxy-isoflavan and its precursors is shown in Structural Elucidation of Hydroxylated Metabolites of the Isoflavan Equol by GC/MS and HPLC/MS by Corinna E. Rüfer, Hansruedi Glatt, and Sabine E. Kulling in Drug Metabolism and Disposition (2005, electronic publication).
  2. 1 2 Wang XL, Hur HG, Lee JH, Kim KT, Kim SI (January 2005). "Enantioselective synthesis of S-equol from dihydrodaidzein by a newly isolated anaerobic human intestinal bacterium". Appl. Environ. Microbiol. 71 (1): 214–9. Bibcode:2005ApEnM..71..214W. doi:10.1128/AEM.71.1.214-219.2005. PMC   544246 . PMID   15640190.
  3. 1 2 3 Muthyala, Rajeev S; Ju, Young H; Sheng, Shubin; Williams, Lee D; Doerge, Daniel R; Katzenellenbogen, Benita S; Helferich, William G; Katzenellenbogen, John A (2004). "Equol, a natural estrogenic metabolite from soy isoflavones". Bioorganic & Medicinal Chemistry. 12 (6): 1559–1567. doi:10.1016/j.bmc.2003.11.035. ISSN   0968-0896. PMID   15018930.
  4. ↑ Frankenfeld CL, Atkinson C, Thomas WK, et al. (December 2005). "High concordance of daidzein-metabolizing phenotypes in individuals measured 1 to 3 years apart". Br. J. Nutr. 94 (6): 873–6. doi: 10.1079/bjn20051565 . PMID   16351761.
  5. ↑ Marrian, GF; Haslewood, GA (1932). "Equol, a new inactive phenol isolated from the ketohydroxyoestrin fraction of mares' urine". The Biochemical Journal. 26 (4): 1227–32. doi:10.1042/bj0261227. PMC   1261026 . PMID   16744928.
  6. 1 2 3 Setchell, KD; Clerici, C (July 2010). "Equol: history, chemistry, and formation". The Journal of Nutrition. 140 (7): 1355S–62S. doi:10.3945/jn.109.119776. PMC   2884333 . PMID   20519412.
  7. ↑ Axelson, M; Kirk, DN; Farrant, RD; Cooley, G; Lawson, AM; Setchell, KD (1982-02-01). "The identification of the weak oestrogen equol [7-hydroxy-3-(4'-hydroxyphenyl)chroman] in human urine". The Biochemical Journal. 201 (2): 353–7. doi:10.1042/bj2010353. PMC   1163650 . PMID   7082293.
  8. 1 2 Setchell, KD; Borriello, SP; Hulme, P; Kirk, DN; Axelson, M (September 1984). "Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease". The American Journal of Clinical Nutrition . 40 (3): 569–78. doi:10.1093/ajcn/40.3.569. PMID   6383008. S2CID   4467689.
  9. ↑ Setchell, KD; Brown, NM; Lydeking-Olsen, E (December 2002). "The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones". The Journal of Nutrition. 132 (12): 3577–84. doi: 10.1093/jn/132.12.3577 . PMID   12468591.
  10. 1 2 3 Atkinson, C; Frankenfeld, CL; Lampe, JW (March 2005). "Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health". Experimental Biology and Medicine. 230 (3): 155–70. doi:10.1177/153537020523000302. PMID   15734719. S2CID   14112442.
  11. ↑ Mueller SO, Simon S, Chae K, Metzler M, Korach KS (April 2004). "Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor {α} (ER{α}) and ERβ in human cells". Toxicol. Sci. 80 (1): 14–25. doi: 10.1093/toxsci/kfh147 . PMID   15084758.
  12. ↑ Setchell, KD; Clerici, C; Lephart, ED; Cole, SJ; Heenan, C; Castellani, D; Wolfe, BE; Nechemias-Zimmer, L; Brown, NM; Lund, TD; Handa, RJ; Heubi, JE (May 2005). "S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora". The American Journal of Clinical Nutrition . 81 (5): 1072–9. doi: 10.1093/ajcn/81.5.1072 . PMID   15883431.
  13. ↑ Prossnitz, Eric R.; Barton, Matthias (2014). "Estrogen biology: New insights into GPER function and clinical opportunities". Molecular and Cellular Endocrinology. 389 (1–2): 71–83. doi:10.1016/j.mce.2014.02.002. ISSN   0303-7207. PMC   4040308 . PMID   24530924.
  14. ↑ Setchell, KD; Zhao, X; Jha, P; Heubi, JE; Brown, NM (Oct 2009). "The pharmacokinetic behavior of the soy isoflavone metabolite S-(-)equol and its diastereoisomer R-(+)equol in healthy adults determined by using stable-isotope-labeled tracers". The American Journal of Clinical Nutrition . 90 (4): 1029–37. doi:10.3945/ajcn.2009.27981. PMC   2744624 . PMID   19710188.
  15. ↑ Setchell, KD; Zhao, X; Shoaf, SE; Ragland, K (Nov 2009). "The pharmacokinetics of S-(-)equol administered as SE5-OH tablets to healthy postmenopausal women". The Journal of Nutrition. 139 (11): 2037–43. doi: 10.3945/jn.109.110874 . PMID   19776178.
  16. ↑ Setchell, KD; Clerici, C (Jul 2010). "Equol: pharmacokinetics and biological actions". The Journal of Nutrition. 140 (7): 1363S–8S. doi:10.3945/jn.109.119784. PMC   2884334 . PMID   20519411.
  17. ↑ Lampe, JW; Karr, SC; Hutchins, AM; Slavin, JL (March 1998). "Urinary equol excretion with a soy challenge: influence of habitual diet". Proceedings of the Society for Experimental Biology and Medicine. 217 (3): 335–9. doi:10.3181/00379727-217-44241. PMID   9492344. S2CID   23496918.
  18. ↑ Setchell, KD; Cole, SJ (August 2006). "Method of defining equol-producer status and its frequency among vegetarians". The Journal of Nutrition. 136 (8): 2188–93. doi: 10.1093/jn/136.8.2188 . PMID   16857839.
  19. ↑ Rowland, IR; Wiseman, H; Sanders, TA; Adlercreutz, H; Bowey, EA (2000). "Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora". Nutrition and Cancer. 36 (1): 27–32. doi:10.1207/S15327914NC3601_5. PMID   10798213. S2CID   10603402.
  20. ↑ Watanabe, S; Yamaguchi, M; Sobue, T; Takahashi, T; Miura, T; Arai, Y; Mazur, W; Wähälä, K; Adlercreutz, H (October 1998). "Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako)". The Journal of Nutrition. 128 (10): 1710–5. doi: 10.1093/jn/128.10.1710 . PMID   9772140.
  21. ↑ Arai, Y; Uehara, M; Sato, Y; Kimira, M; Eboshida, A; Adlercreutz, H; Watanabe, S (March 2000). "Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake". Journal of Epidemiology. 10 (2): 127–35. doi: 10.2188/jea.10.127 . PMID   10778038.
  22. ↑ Akaza, H; Miyanaga, N; Takashima, N; Naito, S; Hirao, Y; Tsukamoto, T; Fujioka, T; Mori, M; Kim, WJ; Song, JM; Pantuck, AJ (February 2004). "Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents". Japanese Journal of Clinical Oncology. 34 (2): 86–9. doi: 10.1093/jjco/hyh015 . PMID   15067102.
  23. ↑ Song, KB; Atkinson, C; Frankenfeld, CL; Jokela, T; Wähälä, K; Thomas, WK; Lampe, JW (May 2006). "Prevalence of daidzein-metabolizing phenotypes differs between Caucasian and Korean American women and girls". The Journal of Nutrition. 136 (5): 1347–51. doi: 10.1093/jn/136.5.1347 . PMID   16614428.
  24. ↑ Patisaul, HB; Jefferson, W (October 2010). "The pros and cons of phytoestrogens". Front Neuroendocrinol. 31 (4): 400–419. doi:10.1016/j.yfrne.2010.03.003. PMC   3074428 . PMID   20347861.
  25. ↑ Teas, J.; Hurley, TG (August 2009). "Dietary seaweed modifies estrogen and phytoestrogen metabolism in healthy postmenopausal women". The Journal of Nutrition. 139 (9): 939–44. doi: 10.3945/jn.108.100834 . PMID   19321575.
  26. ↑ Setchell, KD; Cole, SJ (August 2006). "Method of defining equol-producer status and its frequency among vegetarians". The Journal of Nutrition. 136 (8): 2188–93. doi: 10.1093/jn/136.8.2188 . PMID   16857839.
  27. ↑ Setchell KD, Clerici C, Lephart ED, Cole SJ, Heenan C, Castellani D, Wolfe BE, Nechemias-Zimmer L, Brown NM, Lund TD, Handa RJ, Heubi JE (2005). "S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora". Am. J. Clin. Nutr. 81 (5): 1072–9. doi: 10.1093/ajcn/81.5.1072 . PMID   15883431.
  28. ↑ Setchell, K. D.; Clerici, C. (2010). "Equol: History, Chemistry, and Formation". The Journal of Nutrition. 140 (7): 1355S–1362S. doi:10.3945/jn.109.119776. PMC   2884333 . PMID   20519412.
  29. ↑ V, Ravishankar Rai; Bai, Jamuna A. (2014-12-17). Beneficial Microbes in Fermented and Functional Foods. CRC Press. ISBN   978-1-4822-0663-0.
  30. ↑ Reeve V, Widyarini S, Domanski D, Chew K, Barnes K. Protection Against Photoaging in the Hairless Mouse by the Isoflavone Equol. Photochemistry and Photobiology, Volume 81, Issue 6, November 2005, Pages 1548-1553
  31. ↑ Magnet, U.; Urbanek, C.; Gaisberger, D.; Tomeva, E.; Dum, E.; Pointner, A.; Haslberger, A.G. (October 2017). "Topical equol preparation improves structural and molecular skin parameters". International Journal of Cosmetic Science. 39 (5): 535–542. doi:10.1111/ics.12408. PMID   28574180. S2CID   44910993.
  32. ↑ Lephart ED (November 2016). "Skin aging and oxidative stress: Equol's anti-aging effects via biochemical and molecular mechanisms". Ageing Research Reviews . 31: 36–54. doi:10.1016/j.arr.2016.08.001. PMID   27521253. S2CID   205668316.
  33. ↑ Urbanek C, Haslberger A, Hippe B, Gessner D, Fiala H, Equol – a Topically Applied Phyto-Oestrogen Improves Skin Characteristics. Global ingredients and Formulations Guide 2016
  34. ↑ Lephart, Edwin (2018-01-29). "Equol's Anti-Aging Effects Protect against Environmental Assaults by Increasing Skin Antioxidant Defense and ECM Proteins While Decreasing Oxidative Stress and Inflammation". Cosmetics. 5 (1): 16. doi: 10.3390/cosmetics5010016 . ISSN   2079-9284.
  35. 1 2 Lephart, Edwin D. (November 2013). "Protective effects of equol and their polyphenolic isomers against dermal aging: Microarray/protein evidence with clinical implications and unique delivery into human skin". Pharmaceutical Biology. 51 (11): 1393–1400. doi: 10.3109/13880209.2013.793720 . ISSN   1388-0209. PMID   23862588.
  36. ↑ Efficacy and safety of natural S-equol supplement in US postmenopausal women. Belinda H. Jenks of Scientific Affairs, Pharmavite LLC, Northridge, CA, et.al.
  37. ↑ Effect of natural S-equol on bone metabolism in equol non-producing postmenopausal Japanese women: a pilot randomized placebo-controlled trial. Tomomi Ueno of Saga Nutraceutricals Research Institute, Otsuka Pharmaceutical Co., Ltd., Japan, et.al
  38. ↑ Mayr, Linda; Georgiev, Dimitar; Toulev, Albena (2019-03-01). "Eine Proof-of-concept-Studie von Isoflavandiol-E55-RS-Vaginalkapseln oder Vaginalgel zur Linderung der menopausalen Vaginalatrophie". Journal für Gynäkologische Endokrinologie/Österreich (in German). 29 (1): 13–22. doi: 10.1007/s41974-019-0085-9 . ISSN   1996-1553.
  39. ↑ "Equol Is a Novel Anti-Androgen that Inhibits Prostate Growth and Hormone Feedback, Biology of Reproduction, Volume 70, Issue 4, 1 April 2004, Pages 1188–1195" . Retrieved 2023-11-17.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.